BLEND THERAPEUTICS INC has a total of 16 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are PHOSPLATIN THERAPEUTICS LLC, NIIKI PHARMA ACQUISITION CORP 2 and RUBICON RES PVT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | China | 2 | |
#3 | United States | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Singapore | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bilodeau Mark T | 16 |
#2 | Wooster Richard | 11 |
#3 | Kadiyala Sudhakar | 11 |
#4 | Shinde Rajesh | 9 |
#5 | Barder Timothy Edward | 8 |
#6 | White Brian | 8 |
#7 | Moreau Benoît | 6 |
#8 | Dunbar Craig A | 3 |
#9 | Whalen Kerry | 3 |
#10 | Shinde Rajesh R | 3 |
Publication | Filing date | Title |
---|---|---|
CN106659706A | Platinum compounds, compositions, and uses thereof | |
WO2015102928A1 | Compounds, compositions, and methods for the treatment of cancers | |
WO2015102922A1 | Compounds, compositions, and methods for the treatment of cancers | |
US2014187501A1 | Targeted Conjugates Encapsulated in Particles and Formulations Thereof | |
WO2014100417A1 | Compounds, compositions, and methods for the treatment of cancers |